萧山生物医药产业再添新引擎：审评检查服务中心正式揭牌

Core Viewpoint - The collaboration between Zhejiang Provincial Drug Administration and Xiaoshan District marks a significant step in deepening drug regulation reform, injecting new momentum into the high-quality development of the biopharmaceutical industry in Xiaoshan [1][2]. Group 1: Agreements and Initiatives - A cooperation agreement was signed to accelerate the high-quality development of the biopharmaceutical industry in Xiaoshan, alongside a pilot cooperation agreement for provincial, municipal, and district-level inspections [1]. - The establishment of the Drug and Medical Device Review and Inspection Service Center in Xiaoshan aims to provide one-stop services including business consultation, regulatory training, and pre-inspection [1]. Group 2: Industry Impact - The service center is expected to support medical device companies significantly, enhancing the local business environment and providing professional assistance [2]. - The center is viewed as a "differentiated ace" for attracting investment in the competitive landscape of current market conditions [2]. - The collaboration and initiatives are set to create a new high ground for the biopharmaceutical industry in Xiaoshan, offering robust support for the development of new productive forces [2].